Approval obtained for a phase I clinical study for a Russian company

This is an open-label, randomized, two-stage clinical trial to evaluate the pharmacokinetics and the safety of a combination drug, aimed to ease the lower back pain. It will be a single and multiple dosing trial with more than 30 people included. 

In this project, OCT is responsible for medical writing, regulatory support, logistics, project management, monitoring, data management and statistics.

OCT has successfully completed over 30 I phase trials. Professional project management and in-depth understanding of the industry ensure fast and effective enrollment.

Back to the list